Cargando…
Drug-induced esophagitis and helpful management for healthcare providers
In recent decades, the number of cases developing drug-induced esophagitis (DIE) has reportedly been growing, which indicates the significance of detecting medicines capable of causing this adverse reaction. This study aims to provide an updated review on recent case reports of DIE, to evaluate the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589134/ https://www.ncbi.nlm.nih.gov/pubmed/36311965 http://dx.doi.org/10.22037/ghfbb.v15i3.2591 |
_version_ | 1784814233830031360 |
---|---|
author | Abdi, Saeed Masbough, Farnoosh Nazari, Maryam Abbasinazari, Mohammad |
author_facet | Abdi, Saeed Masbough, Farnoosh Nazari, Maryam Abbasinazari, Mohammad |
author_sort | Abdi, Saeed |
collection | PubMed |
description | In recent decades, the number of cases developing drug-induced esophagitis (DIE) has reportedly been growing, which indicates the significance of detecting medicines capable of causing this adverse reaction. This study aims to provide an updated review on recent case reports of DIE, to evaluate the possible mechanism of this side effect, and to provide helpful management. Data was gathered through searches of three databases, namely PubMed, Medline, and Cochrane. Seven drug categories were evaluated: antibiotics, bisphosphonates, cardiovascular medicines, chemotherapeutic agents, non-steroidal anti-inflammatory drugs (NSAIDs), other medications, and supplements. According to the findings, retrosternal pain, heartburn, odynophagia, and dysphagia are typical symptoms of DIE, and in most cases, DIE is a self-limiting side effect which can be resolved by removing the causative agent and providing supportive therapy. |
format | Online Article Text |
id | pubmed-9589134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-95891342022-10-28 Drug-induced esophagitis and helpful management for healthcare providers Abdi, Saeed Masbough, Farnoosh Nazari, Maryam Abbasinazari, Mohammad Gastroenterol Hepatol Bed Bench Review Article In recent decades, the number of cases developing drug-induced esophagitis (DIE) has reportedly been growing, which indicates the significance of detecting medicines capable of causing this adverse reaction. This study aims to provide an updated review on recent case reports of DIE, to evaluate the possible mechanism of this side effect, and to provide helpful management. Data was gathered through searches of three databases, namely PubMed, Medline, and Cochrane. Seven drug categories were evaluated: antibiotics, bisphosphonates, cardiovascular medicines, chemotherapeutic agents, non-steroidal anti-inflammatory drugs (NSAIDs), other medications, and supplements. According to the findings, retrosternal pain, heartburn, odynophagia, and dysphagia are typical symptoms of DIE, and in most cases, DIE is a self-limiting side effect which can be resolved by removing the causative agent and providing supportive therapy. Shaheed Beheshti University of Medical Sciences 2022 /pmc/articles/PMC9589134/ /pubmed/36311965 http://dx.doi.org/10.22037/ghfbb.v15i3.2591 Text en ©2022 RIGLD, Research Institute for Gastroenterology and Liver Diseases https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) which permits others to copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Review Article Abdi, Saeed Masbough, Farnoosh Nazari, Maryam Abbasinazari, Mohammad Drug-induced esophagitis and helpful management for healthcare providers |
title | Drug-induced esophagitis and helpful management for healthcare providers |
title_full | Drug-induced esophagitis and helpful management for healthcare providers |
title_fullStr | Drug-induced esophagitis and helpful management for healthcare providers |
title_full_unstemmed | Drug-induced esophagitis and helpful management for healthcare providers |
title_short | Drug-induced esophagitis and helpful management for healthcare providers |
title_sort | drug-induced esophagitis and helpful management for healthcare providers |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589134/ https://www.ncbi.nlm.nih.gov/pubmed/36311965 http://dx.doi.org/10.22037/ghfbb.v15i3.2591 |
work_keys_str_mv | AT abdisaeed druginducedesophagitisandhelpfulmanagementforhealthcareproviders AT masboughfarnoosh druginducedesophagitisandhelpfulmanagementforhealthcareproviders AT nazarimaryam druginducedesophagitisandhelpfulmanagementforhealthcareproviders AT abbasinazarimohammad druginducedesophagitisandhelpfulmanagementforhealthcareproviders |